FDA Expands Indication for Gilead's Vemlidy (tenofovir alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
March 28, 2024 -- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 28, 2024 Category: Drugs & Pharmacology Source Type: news

Dapivirine Vaginal Ring Safe, Effective at Preventing HIV During Pregnancy
THURSDAY, March 14, 2024 -- Adverse pregnancy outcomes related to use of the dapivirine vaginal ring (DVR) or daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) during the second trimester are uncommon, according to a study presented... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 14, 2024 Category: Pharmaceuticals Source Type: news

Strides Pharma gets USFDA nod to market HIV drug
The company's product is bioequivalent and therapeutically equivalent to Atripla Tablets of Gilead Sciences LLC, it added. As per per IQVIA, Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumurate tablet (EET) has a market opportunity of USD 7.5 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2023 Category: Pharmaceuticals Source Type: news

Hypertension, Statin Use Increased for Individuals Using TAF for PrEP
THURSDAY, Sept. 14, 2023 -- For individuals taking preexposure prophylaxis (PrEP) for preventing HIV infection, tenofovir alafenamide fumarate (TAF) use is associated with higher incident hypertension and statin initiation compared with tenofovir... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2023 Category: Pharmaceuticals Source Type: news

One PrEP Regimen Linked to Higher Risk of Hypertension, Statin Use Over Another
(MedPage Today) -- Use of tenofovir alafenamide fumarate (TAF) for HIV pre-exposure prophylaxis (PrEP) was associated with an increased risk of hypertension and the initiation of statin use within 2 years compared with the use of tenofovir disoproxil... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 11, 2023 Category: Cardiology Source Type: news

Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV
(MedPage Today) -- VIENNA -- Tenofovir alafenamide (TAF; Biktarvy) continued to be highly effective for chronic hepatitis B virus (HBV) infection for up to 8 years, according to an analysis of long-term data. Over this time period, viral suppression... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 26, 2023 Category: Gastroenterology Source Type: news

Tenofovir vs Entecavir After Treatment for HBV-related HCC Tenofovir vs Entecavir After Treatment for HBV-related HCC
This review compared the efficacy of entecavir and tenofovir for reducing the risk of recurrence and mortality after curative therapy for HBV-related hepatocellular carcinoma.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 20, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
The tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for AIDS relief (PEPFAR), Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2023 Category: Pharmaceuticals Source Type: news

Weight Gain and Metabolic Effects of INSTI-Based ART or TAF Weight Gain and Metabolic Effects of INSTI-Based ART or TAF
A new study analyzed the BMI changes among people with HIV who switched to an ART regimen that included integrase inhibitors or tenofovir alafenamide.JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 2, 2023 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

HIV Prevention: New Injection Could Boost the Fight, But Some Hurdles Remain
This article is republished from The Conversation under a Creative Commons license. Read the original article. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 30, 2022 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs #HIV/Aids Source Type: news

Tenofovir, Vaccine Combo Eliminates Mom-to-Child HBV Transmission
(MedPage Today) -- Earlier maternal tenofovir disoproxil fumarate (TDF) combined with infant vaccination completely eliminated vertical transmission of chronic hepatitis B virus (HBV) from highly viremic mothers, even without the use of hepatitis... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 8, 2022 Category: Gastroenterology Source Type: news

U.S. Food and Drug Administration Approves Vemlidy (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients
Approval Expands on Previous FDA Approval of Vemlidy in Adults Living With This Chronic Liver Disease Efficacy and Safety of Once-Daily Vemlidy Demonstrated in Individuals 12 Years of Age and Older FOSTER CITY, Calif.--(BUSINESS WIRE) November... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 2, 2022 Category: Drugs & Pharmacology Source Type: news

A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation
In people with suppressed HIV, including those with the M184V/I viral mutation, switching to combined bictegravir, emtricitabine, and tenofovir alafenamide has high efficacy, researchers report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2022 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

TDF Therapy to Prevent HBV Vertical Transmission TDF Therapy to Prevent HBV Vertical Transmission
This study investigated the efficacy and safety of tenofovir disoproxil fumarate administration to prevent HBV mother-to-child transmissionLiver International (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - September 6, 2022 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Dual Therapy Holds Its Own in Treatment-Naive HIV
(MedPage Today) -- MONTREAL -- A two-drug combination using a generic formulation of the protease inhibitor darunavir/ritonavir plus lamivudine appeared to control HIV as well as the same combination with added tenofovir, according to results... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - August 2, 2022 Category: Infectious Diseases Source Type: news